View in EDS HTML Full Text PDF Full Text

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.

Saved in:
Bibliographic Details
Title: Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
Authors: Matossian MD; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA., Elliott S; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA., Rhodes LV; Department of Biology, Florida Gulf Coast University, Fort Myers, FL 33965, USA., Martin EC; Department of Biological and Agricultural Engineering Biology, Louisiana State University, Baton Rouge, LA 70803, USA., Hoang VT; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA., Burks HE; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA., Zuercher WJ; Structural Genomics Consortium, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA., Drewry DH; Structural Genomics Consortium, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA., Collins-Burow BM; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA., Burow ME; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Source: Oncology letters [Oncol Lett] 2021 May; Vol. 21 (5), pp. 380. Date of Electronic Publication: 2021 Mar 16.
Publication Type: Journal Article
Journal Info: Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1792-1074 (Print) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33777204
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matossian+MD%22">Matossian MD</searchLink>; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.<br /><searchLink fieldCode="AU" term="%22Elliott+S%22">Elliott S</searchLink>; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.<br /><searchLink fieldCode="AU" term="%22Rhodes+LV%22">Rhodes LV</searchLink>; Department of Biology, Florida Gulf Coast University, Fort Myers, FL 33965, USA.<br /><searchLink fieldCode="AU" term="%22Martin+EC%22">Martin EC</searchLink>; Department of Biological and Agricultural Engineering Biology, Louisiana State University, Baton Rouge, LA 70803, USA.<br /><searchLink fieldCode="AU" term="%22Hoang+VT%22">Hoang VT</searchLink>; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.<br /><searchLink fieldCode="AU" term="%22Burks+HE%22">Burks HE</searchLink>; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.<br /><searchLink fieldCode="AU" term="%22Zuercher+WJ%22">Zuercher WJ</searchLink>; Structural Genomics Consortium, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Drewry+DH%22">Drewry DH</searchLink>; Structural Genomics Consortium, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.<br /><searchLink fieldCode="AU" term="%22Collins-Burow+BM%22">Collins-Burow BM</searchLink>; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.<br /><searchLink fieldCode="AU" term="%22Burow+ME%22">Burow ME</searchLink>; Department of Medicine, Section of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101531236%22">Oncology letters</searchLink> [Oncol Lett] 2021 May; Vol. 21 (5), pp. 380. <i>Date of Electronic Publication: </i>2021 Mar 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Spandidos+Publications]%22">Spandidos Publications] </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>101531236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1792-1074 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217921074%22">17921074 </searchLink><i>NLM ISO Abbreviation: </i>Oncol Lett <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33777204
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3892/ol.2021.12641
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 380
    Titles:
      – TitleFull: Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matossian MD
      – PersonEntity:
          Name:
            NameFull: Elliott S
      – PersonEntity:
          Name:
            NameFull: Rhodes LV
      – PersonEntity:
          Name:
            NameFull: Martin EC
      – PersonEntity:
          Name:
            NameFull: Hoang VT
      – PersonEntity:
          Name:
            NameFull: Burks HE
      – PersonEntity:
          Name:
            NameFull: Zuercher WJ
      – PersonEntity:
          Name:
            NameFull: Drewry DH
      – PersonEntity:
          Name:
            NameFull: Collins-Burow BM
      – PersonEntity:
          Name:
            NameFull: Burow ME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2021 May
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1792-1074
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Oncology letters
              Type: main
ResultId 1